The 3rd Nordic Conference on Paediatric Medicines will take place 8-9.October in Helsinki, Finland.

EU Paediatric Regulation (EC 1901/2006) came into force in 2007 with the aim to improve the health of the children in Europe by increasing the research and authorization of medicines for children and improving the information on medicines designed for children. To meet the objectives of the regulation, an increasing number of pediatric clinical trials needs to be conducted. This requires more research capacity; increasing demand for investigators, centres and networks in Europe.

Since 2013, the Pharma Industry Finland together with the Finnish Investigators Network for Pediatric Medicines – FinPedMed – have been facilitating Academic and Pharma Industry collaboration for pediatric clinical trials in the Nordic area.

This 3rd Nordic conference will facilitate and bring forward ideas for discussion in order to accelerate medicine development for children, by providing the most appropriate context for new solutions, and updating the current information related paediatric clinical trials.

The conference will be attended by Estonian Paediatric Research Group representatives Jana Lass, Piia Jõgi, Heli Rajasaar, Hanna Helena Pärn, Birgit Kiilaspää, Mari Laan; CEO of Clinical Research Centre and Tartu University Hospital Clinical Research Coordinator Dr Katrin Kaarna and Tallinn Children’s Hospital representative Dr Kristi Lepik.